CD11c C-terminal Antibody

About the Target

CD11c (integrin αX, ITGAX) is a transmembrane glycoprotein that pairs with CD18 (integrin β2) to form an α/β heterodimer. This complex interacts with various extracellular matrix components and cell surface proteins. CD11c is commonly used as a marker for dendritic cells, which can be divided into two main categories: CD11c+ conventional dendritic cells, which are specialized in antigen presentation, and CD11c- plasmacytoid dendritic cells, which focus on producing type I interferons. Depending on the literature source, CD11C may also be discussed as CD11c C-terminal.

Reported cellular context includes membrane, which can matter when signal is compared across treatments or changing cell states. Following CD11C across matched perturbations can help separate abundance effects from shifts in localization, complex assembly, or pathway state.

Research Context

CD11C is commonly interpreted in the context of immunology research, and readouts are often stronger when a study separates expression changes from compartment-level redistribution. When reported signal spans membrane, a defined reference condition can make comparisons more interpretable across perturbations, passages, or replicate sets.

Consider these angles when interpreting target-level changes:

• signal enrichment within membrane relative to the broader cellular background
• context differences tied to immune-cell state, activation, or lineage composition
• co-patterning with orthogonal markers and control conditions that clarify pathway state
• time-matched comparisons so changes reflect biology rather than handling or sampling drift

Variant Considerations

If your project spans exploratory questions, the regular version offers a balanced option for establishing baseline signal behavior for CD11C. This can help when protocols evolve over time and the goal is to compare experiments using a stable reference workflow.

Standardize sampling time, control choice, and downstream analysis thresholds so apparent differences in CD11C reflect biology rather than handling. When interpreting CD11C, it is often useful to decide early whether the main question is overall abundance, compartmental enrichment, or context-dependent redistribution.

For multi-run studies, a shared reference condition can keep CD11C trends easier to compare across datasets. That kind of consistency is especially helpful when follow-up work expands to new perturbations, model systems, or longitudinal collections.